Redmile Group LLC 13D and 13G filings for Entrada Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:26 pm Sale | 2023-12-31 | 13G | ENTRADA THERAPEUTICS INC TRDA | Redmile Group LLC | 1,283,735 3.800% | -570,373 (-30.76%) | Filing |
| 2023-02-14 4:25 pm Sale | 2022-12-31 | 13G | ENTRADA THERAPEUTICS INC TRDA | Redmile Group LLC | 1,854,108 5.900% | -100,312 (-5.13%) | Filing |
| 2022-02-14 5:07 pm Purchase | 2021-12-31 | 13G | ENTRADA THERAPEUTICS INC TRDA | Redmile Group LLC | 1,954,420 6.300% | 1,954,420 (New Position) | Filing |